Group One Trading
VIR icon

Group One Trading’s Vir Biotechnology VIR Stock Holding History

Group One Trading’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$478K Buy
53,400
+50,100
+1,518% +$399K ﹤0.01% 3388
2025
Q4 		$19.9K Buy
3,300
+2,600
+371% +$15.5K ﹤0.01% 6339
2025
Q3 		$4K Sell
700
-13,300
-95% -$68K ﹤0.01% 7651
2025
Q2 		$70.6K Sell
14,000
-4,000
-22% -$21.4K ﹤0.01% 5273
2025
Q1 		$117K Buy
18,000
+11,400
+173% +$101K ﹤0.01% 4475
2024
Q4 		$48.4K Sell
6,600
-11,900
-64% -$93.9K ﹤0.01% 5079
2024
Q3 		$139K Sell
18,500
-24,800
-57% -$215K ﹤0.01% 3920
2024
Q2 		$385K Sell
43,300
-29,500
-41% -$283K ﹤0.01% 2811
2024
Q1 		$737K Sell
72,800
-46,000
-39% -$468K ﹤0.01% 2364
2023
Q4 		$1.2M Buy
118,800
+76,200
+179% +$696K ﹤0.01% 2307
2023
Q3 		$399K Buy
42,600
+34,400
+420% +$491K ﹤0.01% 3135
2023
Q2 		$201K Sell
8,200
-42,300
-84% -$1.06M ﹤0.01% 3921
2023
Q1 		$1.18M Buy
50,500
+47,400
+1,529% +$1.21M ﹤0.01% 1992
2022
Q4 		$78.5K Sell
3,100
-11,700
-79% -$287K ﹤0.01% 4652
2022
Q3 		$285K Sell
14,800
-26,400
-64% -$671K ﹤0.01% 3797
2022
Q2 		$1.05M Sell
41,200
-69,800
-63% -$1.63M ﹤0.01% 2713
2022
Q1 		$2.85M Sell
111,000
-30,900
-22% -$916K ﹤0.01% 2041
2021
Q4 		$5.94M Buy
141,900
+41,200
+41% +$1.61M ﹤0.01% 1554
2021
Q3 		$4.38M Buy
100,700
+62,900
+166% +$2.72M ﹤0.01% 1839
2021
Q2 		$1.79M Sell
37,800
-37,900
-50% -$1.72M ﹤0.01% 2779
2021
Q1 		$3.88M Buy
75,700
+50,900
+205% +$2.74M 0.01% 1786
2020
Q4 		$664K Buy
24,800
+10,200
+70% +$332K ﹤0.01% 3031
2020
Q3 		$501K Sell
14,600
-10,800
-43% -$465K ﹤0.01% 2845
2020
Q2 		$1.04M Buy
25,400
+19,300
+316% +$648K ﹤0.01% 1982
2020
Q1 		$209K Buy
+6,100
New +$164K ﹤0.01% 2722

Other funds holding VIR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
GP
GSK plc London $599M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Group One Trading's VIR Position: Q1 2026 in Review

Group One Trading sold out of Vir Biotechnology (VIR) in Q1 2026, closing a stake of 3,554 shares — an estimated $28.3K sold.

Group One Trading first reported a position in VIR in Q3 2020 and held it in 10 quarters. The position peaked at $1.32M in Q4 2024. 251 funds tracked by Wall St. Rank hold VIR as of Q1 2026.

  • Group One Trading reported no remaining Vir Biotechnology position as of Q1 2026 after selling out during the quarter.
  • Group One Trading sold 3,554 Vir Biotechnology shares in Q1 2026, an estimated $28.3K.
  • Group One Trading first reported a position in Vir Biotechnology in Q3 2020 and held it in 10 quarters.
  • Group One Trading's Vir Biotechnology position peaked at $1.32M in Q4 2024.
  • 251 funds tracked by Wall St. Rank held Vir Biotechnology as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.